Market acceptance of the Biote Method
Revenue depends on clinics and practitioners adopting the training and treatment model.
- Scope
- Practitioner network and patient demand
- Materiality
- high
biote Corp.
biote Corp. is a U.S.-based healthcare company focused on hormone optimization through a practice-building platform for physicians and nurse practitioners. Its business combines practitioner training and certification, clinic management software, marketing support, and sales of Biote-branded dietary supplements and related hormone therapy products.
20,4 %
14,1 %
−2,5 %
1.22
0.79
| % | |
|---|---|
| Practice-building platform | 55% Training, certification, software, and marketing tools for Biote-certified practitioners. |
| Procedure-related products and services | 25% Bioidentical hormone pellets, insertion kits, and related procedure-based fees sold to clinics. |
| Dietary supplements | 20% Biote-branded supplements sold through practitioners and direct-to-consumer channels. |
Biote sells primarily to clinics, physicians, and nurse practitioners that join its certified practitioner network and...
- Biote-partnered clinicsprimary
Clinics that pay fees for the Biote Method, software, training, and ongoing practice support.
- Biote-certified practitionersprimary
Physicians and nurse practitioners who use the training and clinical workflow to treat patients.
- Supplement buyerssecondary
Patients and consumers purchasing Biote-branded dietary supplements for hormone and wellness support.
Substantially all revenue comes from clinics located in the United States, making the business highly concentrated in...
- •Substantially all revenue originates in the United States
- •Clinic and practitioner network is built around U.S. markets
- •Sales efforts target domestic specialties and local footprints
- •U.S. healthcare regulation and reimbursement trends matter
- •Consumer marketing is directed to U.S. patients and clinics
Biote’s strategy is to expand the number of certified practitioners and deepen activity within its existing clinic...
01
Increase the number of Biote-certified practitionersshort-term
More certified practitioners expand the installed base that uses the platform and buys products.
02
Grow existing clinic productivitymedium-term
Higher procedure volume and broader product adoption increase revenue from the current network.
03
Expand consumer and brand reachmedium-term
Consumer awareness can drive patient demand and support practitioner recruitment.
Biote depends on acceptance of hormone optimization methods and on continued willingness of clinics and practitioners...
HRT safety and reputational risk
Negative publicity or perceived side effects could reduce practitioner and patient willingness to use the therapy.
- Scope
- Hormone optimization treatments
- Materiality
- high
Regulatory and reimbursement pressure
Healthcare rules and reimbursement trends can change clinic economics and treatment adoption.
- Scope
- U.S. medical practices
- Materiality
- high
Intellectual property and brand protection
Unauthorized copying of supplements, software, or trade secrets could weaken differentiation.
- Scope
- Biote-branded supplements and technology
- Materiality
- medium
Customer concentration
Substantially all revenue comes from U.S. clinics, so localized disruption can affect results.
- Scope
- Domestic clinic network
- Materiality
- high
Revenue recognition for bundled contracts
Timing and mix of revenue between product and service lines
Procedure-based and shipment-based recognition
Quarterly revenue can shift with procedure timing and shipments
Inventory valuation
Gross margin and asset carrying values
Earnout liability fair value
Non-cash gains or losses in earnings
: 29.4.2026